What question did this study set out to answer?

This research aims to identify the role of missed or delayed infusions in relapses among NMOSD patients on Inebilizumab.

June 13, 2026Neurology

Missed or Delayed Infusions as Probable Culprits for Relapses in NMOSD Patients on Inebilizumab: A Real-world Study in a Predominantly Hispanic Cohort (P8-2.007)

View Full Paper

Ask AI

Bookmark

Authors

Real-world outcomes reveal the impact of infusion delays on relapses in a Hispanic cohort, suggesting improved management strategies.

This research aims to identify the role of missed or delayed infusions in relapses among NMOSD patients on Inebilizumab.
Real-world study focusing on a predominantly Hispanic patient population
Assessment of infusion adherence and its correlation with relapse rates
Identified a significant association between missed infusions and increased relapse rates in NMOSD patients
Demonstrated that timely infusion is crucial for reducing the risk of relapses

Leal et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark